Professor James Ritter
MA, DPhil, FRCP, FMedSci, HonFBPhS
Fellow Commoner in Pharmacology
Professor Ritter is Emeritus Professor of Clinical Pharmacology at Kings College London and a Fellow of the British Pharmacological Society. He has made important contributions to our understanding of prostaglandin biosynthesis, particularly that low dose aspirin is an inhibitor of thomboxane biosynthesis that relatively spares prostacyclin. He has worked on endothelial dysfunction in cardiovascular disease, and has pioneered the use of pulse waveform analysis for measuring endothelial function non-invasively, as a tool for use in large-scale outcome trials in cardiovascular disease.